Japan Deep Brain Stimulation Devices Market Size & Outlook
Japan deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
Japan deep brain stimulation devices market highlights
- The Japan deep brain stimulation devices market generated a revenue of USD 47.4 million in 2024 and is expected to reach USD 90.4 million by 2030.
- The Japan market is expected to grow at a CAGR of 11.5% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Epilepsy is the most lucrative application segment registering the fastest growth during the forecast period.
Deep brain stimulation devices market data book summary
| Market revenue in 2024 | USD 47.4 million |
| Market revenue in 2030 | USD 90.4 million |
| Growth rate | 11.5% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Epilepsy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, Japan accounted for 3.4% of the global deep brain stimulation devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 17.8 million by 2030.
Dystonia was the largest segment with a revenue share of 71.73% in 2024. Horizon Databook has segmented the Japan deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Long-term cost-effectiveness associated with deep brain stimulation devices is a high-impact rendering driver of Japan market. According to a study published in NCBI, deep brain stimulation is a cost-effective procedure and delivers sustained benefits.
Hence, it is preferred over other conventional treatment options. Major companies operating in Japan deep brain stimulation devices market include Shenzhen Yingchi Technology Co. Ltd., Medtronic plc, Abbott, and Boston Scientific Corp., among others.
Moreover, technological innovations, such as incorporation of robotic assistance, to minimize human errors during surgeries and extensive R&D capabilities are responsible for the country’s largest market share in Asia Pacific.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan deep brain stimulation devices market size, by product, 2018-2030 (US$M)
Japan Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
